Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. SC 13G Stake Amended Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13D Stake Beneficial Ownership Report
  10. 4 Insider Changes in Ownership
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 8-K Event Material agreement · Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Director nominations · Regulation FD disclosure
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 8-K Event Other events
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 8-K Event Other events
  17. 425 Deal Prospectus/Communication re Business Combination
  18. 10-Q Report Quarterly Report
  19. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  20. EFFECT Other Notice of Effectiveness

Page 10 of 38 · 752 filings